Nuclear factor kappaB signaling in atherogenesis.

Area of Science:

• Cardiovascular Biology
• Immunology
• Molecular Biology

Background:

• Atherosclerosis is an inflammatory disease involving macrophage-derived foam cells in the vessel wall.
• Chemokines, cytokines, and growth factors regulate cellular processes influencing plaque development.
• Nuclear factor kappaB (NF-kappaB) is a critical transcription factor in inflammatory responses.

Purpose of the Study:

• To review recent literature on the function of NF-kappaB in inflammatory responses.
• To elucidate the relationship between NF-kappaB and atherosclerosis.
• To examine NF-kappaB's role in balancing pro- and anti-inflammatory genes in atherosclerosis.

Main Methods:

• Literature review of recent studies on NF-kappaB.
• Analysis of NF-kappaB's role in regulating inflammatory gene expression.
• Investigation of NF-kappaB's involvement in cell survival and proliferation in the context of atherosclerosis.

Main Results:

• NF-kappaB regulates numerous proinflammatory genes associated with atherosclerosis.
• NF-kappaB plays a dual role, influencing both pro- and anti-inflammatory pathways.
• NF-kappaB is implicated in cell survival and proliferation, impacting plaque development.

Conclusions:

• NF-kappaB is a central regulator in the inflammatory processes of atherosclerosis.
• Its role extends beyond pro-inflammatory gene regulation to include cell survival and proliferation.
• Understanding NF-kappaB's complex function is crucial for targeting atherosclerosis therapies.